DOI: http://dx.doi.org/10.18203/2349-3933.ijam20221085

Association of hemolysis markers and cortisol level with different severity of sickle cell disease among Sudanese patients

Ream E. Abdelgadir, Abdel Rahim M. Muddathir, Moyssar A. Krama, Ebtehal A. Adam, Osman Abdelgadir, Elharam I. Abd-allah

Abstract


Background: Sickle cell anemia (SCA) is an inherited disorder of hemoglobin. Several biomarkers have been identified, which is essential in the different clinical presentations of the disease. This study aimed to determine the association between hemolysis markers and cortisol level with varying severity groups of Sudanese patients with SCA.

Methods: This descriptive cross-sectional study included 100 patients with sickle cell disease between February 2016 and April 2017. According to Hedo et al scoring, medical history was obtained to conduct disease severity. A total of 3 ml of venous blood was collected from each patient. A complete hemogram was performed using an automated hematology analyzer (Sysmix®-KX-21N). Bilirubin and lactate dehydrogenase (LDH) were estimated using a spectrophotometer, while cortisol was measured using the Elecsys® system 2010 E170. The reticulocyte count was performed manually. Data were analyzed using statistical package for the social sciences (SPSS) version 21 computer software program.

Results: Disease severity was variable and was categorized into; eighteen (18%) patients had mild symptoms, while 70 (70%) patients had moderate disease, and 12 (12%) patients had severe disease. The analysis of variance (ANOVA) test showed that hemoglobin, reticulocyte count, LDH, and direct bilirubin were positively correlated with disease severity, p value: 0.001, 0.04, 0.00, and 0.02, respectively. While indirect bilirubin, total bilirubin, and cortisol did not correlate with disease severity, the p value was (0.248, 0.083, and 0.868, respectively).

Conclusions: This study confirmed that the hemolysis markers (Hb, reticulocyte count, direct bilirubin and LDH) were positively associated with disease severity. In contrast, indirect bilirubin, total bilirubin, and cortisol levels were not associated with the disease severity.


Keywords


Sickle cell disease; hemolysis markSickle cell disease, Hemolysis markers, Cortisol, Disease severityers; Cortisol; disease severity.

Full Text:

PDF

References


Pecker LH, Lanzkron S. Sickle cell Disease. Ann Intern Med. 2021;174(1):ITC1-6.

Charles T. Quinn Biochemical surrogate markers of hemolysis do not correlate with directly measured erythrocyte survival in sickle cell anemia. Am J Hematol. 2016;91(12):1195-201.

Damanhouri GA, Jarullah J, Marouf S, Hindawi SI, Mushtaq G, Kamal MA. Clinical biomarkers in sickle cell disease. Saud J Biol Sci. 2015;22:24-31.

Gueguen A, Mahevas M, Nzouakou R, Hosseini H, Habibi A, Bachir D, et al. Sickle-cell disease stroke throughout life: a retrospective study in an adult referral center. Am J Hematol. 2014;89(3):267-72.

Hebbel RP. Reconstructing sickle cell disease: a data-based analysis of the "hyperhemolysis paradigm" for pulmonary hypertension from the perspective of evidence-based medicine. Am J Hematol. 2011;86:123-54.

Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet. 2010;376:2018-31.

Barcellini W, Fattizzo B, Zaninoni A. Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients. Blood. 2014;124(19):2930-6.

Kristiansen M, Graversen JH, Jacobsen C. Identification of the haemoglobin scavenger receptor. Nature. 2001;409:6817:198-201.

Körmöczi GF, Säemann MD, Buchta C, Peck-Radosavljevic M, Mayr WR, Schwartz DW, et al. Influence of clinical factors on the haemolysis marker haptoglobin. Eur J Clin Invest. 2006;36(3):202-9.

Lehrer-Graiwer J, Howard J, Hemmaway. Long-term dosing in sickle cell disease subjects with GBT440, a novel HbS polymerization inhibitor. Blood. 2016;128(22):2488.

Porter LS, Gil KM, Carson JW, Anthony KK, Ready J. The role of stress and mood in sickle cell disease pain: an analysis of daily diary data. J Health Psychol. 2000;5(1):53-63.

Russell E, Koren G, Rieder M, Van Uum S. Hair cortisol as a biological marker of chronic stress: current status, future directions and unanswered questions. Psychoneuroendocri¬nology. 2012;37:589-601.

El-Hazmi MA, Al-Hazmi AM, Warsy AS. Sickle cell disease in Middle East Arab countries. Indian J Med Res. 2011;134(5):597-610.

Akinlade KS, Atere AD, Olaniyi JA, Rahamon SK, Adewale CO. Serum copeptin and cortisol do not accurately predict sickle cell anaemia vaso-occlusive crisis as C-reactive protein. PLoS One. 2013;8(11):e77913.

Akinbami A, Dosunmu A, Adediran A, Oshinaike O, Adebola P, Arogundade O. Haematological values in homozygous sickle cell disease in steady state and haemoglobin phenotypes AA controls in Lagos, Nigeria. BMC Res Notes. 2012;5:396.

Bagul R, Chandan S, Sane VD, Patil S, Yadav D. Comparative evaluation of C-reactive protein and WBC count in fascial space infections of odontogenic origin. J Maxillofac Oral Surg. 2017;16(2):238-42.

Ahmed AE, Ali YZ, Al-Suliman AM, Albagshi JM, Al Salamah M, Elsayid M, Alanazi WR, Ahmed RA, McClish DK, Al-Jahdali H. The prevalence of abnormal leukocyte count, and its predisposing factors, in patients with sickle cell disease in Saudi Arabia. J Blood Med. 2017;8:185-91.

Antwi-Boasiako C, Ekem I, Abdul-Rahman M, Sey F, Doku A, Dzudzor B, Dankwah GB, Otu KH, Ahenkorah J, Aryee R. Hematological parameters in Ghanaian sickle cell disease patients. J Blood Med. 2018;9:203-9.

Akinbami A, Dosunmu A, Adediran A, Oshinaike O, Adebola P, Arogundade O. Haematological values in homozygous sickle cell disease in steady state and haemoglobin phenotypes AA controls in Lagos, Nigeria. BMC Res Notes. 2012;5:396.

Mikobi TM, Lukusa Tshilobo P, Aloni MN, Mvumbi Lelo G, Akilimali PZ, Muyembe-Tamfum JJ, et al. Correlation between the Lactate Dehydrogenase Levels with Laboratory Variables in the Clinical Severity of Sickle Cell Anemia in Congolese Patients. PLoS One. 2015;10(5):e0123568.

Nsiah K, Dzogbefia VP , Ansong D, Akoto AO, Boateng H, Ocloo D. Pattern of AST and ALT changes in relation to hemolysis in sickle cell disease. Clin Med Blood Disord. 2011;4.

Aleluia MM, da Guarda CC, Santiago RP, Fonseca TC, Neves FI, de Souza RQ, et al. Association of classical markers and establishment of the dyslipidemic sub-phenotype of sickle cell anemia. Lipids Health Dis. 2017;16(1):74.

El-Sonbaty MM, Al Zolaly MAA, El Tarhouny SA, Al Hawsawi ZMH. Assessment of melatonin and cortisol levels in sickle cell anemia children: A single center based study. Biomed Res. 2016;27(3):752-7.

Akinlade KS, Atere AD, Rahamon SK, Olaniyi JA. Serum levels of copeptin, C-reactive protein and cortisol in different severity groups of sickle cell anemia. Niger J Physiol Sci. 2013;159-64.